510(k) K120466

VERIGENE CYP2C19 NUCLEIC ACID TES (2C19) by Nanosphere, Inc. — Product Code NTI

K120466 is an FDA 510(k) premarket notification submitted by Nanosphere, Inc. for the device "VERIGENE CYP2C19 NUCLEIC ACID TES (2C19)". The FDA issued a decision of Substantially Equivalent on November 6, 2012. The device falls under product code NTI (Drug Metabolizing Enzyme Genotyping Systems), a Class II device regulated under 21 CFR 862.3360. Nanosphere, Inc. has at least 10 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
November 6, 2012
Date Received
February 15, 2012
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Drug Metabolizing Enzyme Genotyping Systems
Device Class
Class II
Regulation Number
862.3360
Review Panel
TX
Submission Type

Intended to identify the presence or absence of human genotypic markers encoding drug metaboizing enzymes using dna originating from clinical samples. This type of assay can be used as an aid determining treatment choice and individualizing treatment dose for therapeutics that are metabolized primarily by the specific enzyme tested by the system.